EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar ... be used to treat proliferative diabetic retinopathy (PDR), macular oedema caused by retinal vein occlusion (RVO ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Sierra Space has passed the preliminary design review (PDR) for 18 satellites it is building for the Space Development Agency’s (SDA) future proliferated satellite constellation in low Earth ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

The FDA has implemented new rules for TV and radio drug ads, effective Nov. 20, aimed at making the advertisements more clear and direct in explaining medication risks and side effects, The Sun ...

VIENTIANE: Suffocating under a mountain of debt to China, communist Laos is struggling to tame rampant inflation, with food ...